Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099125

Chief Medical Officer sold 2,321 shares at an average $45.12 ($104,727)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farwell Wildon Chief Medical Officer 2024-08-19 Sale 10b5-1 −2,060 $45.01 $92,721 143,483 D
Farwell Wildon Chief Medical Officer 2024-08-19 Sale 10b5-1 −261 $46.00 $12,006 143,222 D
Open-market sales · 2,321 sh · avg $45.12 · $104,727
Loading xslF345X05/ownership.xml…